| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | succinyl-CoA:3-oxo-acid CoA-transferase activity | 1.55e-05 | 2 | 79 | 2 | GO:0008260 | |
| GeneOntologyMolecularFunction | membrane potential driven uniporter activity | 1.53e-04 | 5 | 79 | 2 | GO:0022810 | |
| GeneOntologyMolecularFunction | CoA-transferase activity | 1.53e-04 | 5 | 79 | 2 | GO:0008410 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 1.38e-06 | 22 | 79 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.57e-05 | 82 | 79 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | long-chain fatty-acyl-CoA catabolic process | 4.33e-05 | 3 | 79 | 2 | GO:0036116 | |
| GeneOntologyBiologicalProcess | ketone body catabolic process | 4.33e-05 | 3 | 79 | 2 | GO:0046952 | |
| GeneOntologyCellularComponent | dendritic spine | 3.65e-05 | 242 | 79 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 4.15e-05 | 247 | 79 | 7 | GO:0044309 | |
| Domain | 3-oxoacid_CoA-transf_A | 1.81e-05 | 2 | 80 | 2 | IPR012792 | |
| Domain | 3-oxoacid_CoA-transf_B | 1.81e-05 | 2 | 80 | 2 | IPR012791 | |
| Domain | CoA_trans | 1.81e-05 | 2 | 80 | 2 | SM00882 | |
| Domain | CoA_transf_AS | 1.81e-05 | 2 | 80 | 2 | IPR004164 | |
| Domain | CoA_trans_fam_I | 1.81e-05 | 2 | 80 | 2 | IPR004165 | |
| Domain | CoA_transf_BS | 1.81e-05 | 2 | 80 | 2 | IPR004163 | |
| Domain | CoA_trans | 1.81e-05 | 2 | 80 | 2 | PF01144 | |
| Domain | 3-oxoacid_CoA-transferase | 1.81e-05 | 2 | 80 | 2 | IPR014388 | |
| Domain | COA_TRANSF_2 | 1.81e-05 | 2 | 80 | 2 | PS01274 | |
| Domain | COA_TRANSF_1 | 1.81e-05 | 2 | 80 | 2 | PS01273 | |
| Domain | Bile_Hydr_Trans | 1.08e-04 | 4 | 80 | 2 | PF04775 | |
| Domain | Thio_Ohase/aa_AcTrfase | 1.08e-04 | 4 | 80 | 2 | IPR006862 | |
| Domain | Acyl-CoA_thioEstase_long-chain | 1.08e-04 | 4 | 80 | 2 | IPR016662 | |
| Domain | Laminin_aI | 1.80e-04 | 5 | 80 | 2 | IPR009254 | |
| Domain | BAAT_C | 1.80e-04 | 5 | 80 | 2 | IPR014940 | |
| Domain | Laminin_I | 1.80e-04 | 5 | 80 | 2 | PF06008 | |
| Domain | Laminin_II | 1.80e-04 | 5 | 80 | 2 | PF06009 | |
| Domain | Laminin_domII | 1.80e-04 | 5 | 80 | 2 | IPR010307 | |
| Domain | BAAT_C | 1.80e-04 | 5 | 80 | 2 | PF08840 | |
| Domain | ConA-like_dom | 3.54e-04 | 219 | 80 | 6 | IPR013320 | |
| Domain | ENaC | 3.75e-04 | 7 | 80 | 2 | IPR004724 | |
| Domain | LAMININ_IVA | 4.99e-04 | 8 | 80 | 2 | PS51115 | |
| Domain | Laminin_B | 4.99e-04 | 8 | 80 | 2 | PF00052 | |
| Domain | LamB | 4.99e-04 | 8 | 80 | 2 | SM00281 | |
| Domain | Na+channel_ASC_CS | 4.99e-04 | 8 | 80 | 2 | IPR020903 | |
| Domain | Laminin_IV | 4.99e-04 | 8 | 80 | 2 | IPR000034 | |
| Domain | ASC | 6.40e-04 | 9 | 80 | 2 | PF00858 | |
| Domain | ASC | 6.40e-04 | 9 | 80 | 2 | PS01206 | |
| Domain | Na+channel_ASC | 6.40e-04 | 9 | 80 | 2 | IPR001873 | |
| Domain | Laminin_G_1 | 9.72e-04 | 11 | 80 | 2 | PF00054 | |
| Domain | Tyr_kinase_rcpt_2_CS | 9.72e-04 | 11 | 80 | 2 | IPR002011 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.16e-03 | 12 | 80 | 2 | PS00239 | |
| Domain | - | 1.78e-03 | 56 | 80 | 3 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 1.87e-03 | 57 | 80 | 3 | IPR023753 | |
| Domain | Laminin_N | 2.09e-03 | 16 | 80 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 2.09e-03 | 16 | 80 | 2 | PS51117 | |
| Domain | Laminin_N | 2.09e-03 | 16 | 80 | 2 | PF00055 | |
| Domain | LamNT | 2.09e-03 | 16 | 80 | 2 | SM00136 | |
| Domain | Pyr_redox_2 | 2.96e-03 | 19 | 80 | 2 | PF07992 | |
| Domain | MAGE_N | 3.27e-03 | 20 | 80 | 2 | SM01392 | |
| Domain | EGF | 3.38e-03 | 235 | 80 | 5 | SM00181 | |
| Domain | MAGE_N | 3.96e-03 | 22 | 80 | 2 | PF12440 | |
| Domain | MAGE_N | 3.96e-03 | 22 | 80 | 2 | IPR021072 | |
| Domain | EGF-like_dom | 4.32e-03 | 249 | 80 | 5 | IPR000742 | |
| Domain | EGF_1 | 4.77e-03 | 255 | 80 | 5 | PS00022 | |
| Domain | Ricin_B_lectin | 5.10e-03 | 25 | 80 | 2 | PF00652 | |
| Domain | EGF-like_CS | 5.26e-03 | 261 | 80 | 5 | IPR013032 | |
| Domain | EGF_2 | 5.61e-03 | 265 | 80 | 5 | PS01186 | |
| Domain | HECT | 5.93e-03 | 27 | 80 | 2 | PF00632 | |
| Domain | HECTc | 5.93e-03 | 27 | 80 | 2 | SM00119 | |
| Domain | HECT_dom | 5.93e-03 | 27 | 80 | 2 | IPR000569 | |
| Domain | HECT | 5.93e-03 | 27 | 80 | 2 | PS50237 | |
| Domain | RICIN | 6.37e-03 | 28 | 80 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 6.37e-03 | 28 | 80 | 2 | PS50231 | |
| Domain | Ricin_B_lectin | 7.29e-03 | 30 | 80 | 2 | IPR000772 | |
| Domain | Glycos_transf_2 | 7.29e-03 | 30 | 80 | 2 | PF00535 | |
| Domain | EGF_LAM_2 | 7.29e-03 | 30 | 80 | 2 | PS50027 | |
| Domain | Glyco_trans_2-like | 7.29e-03 | 30 | 80 | 2 | IPR001173 | |
| Domain | EGF_LAM_1 | 7.29e-03 | 30 | 80 | 2 | PS01248 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 1.58e-05 | 14 | 51 | 3 | MM15840 | |
| Pathway | WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS | 1.97e-05 | 15 | 51 | 3 | M39789 | |
| Pathway | WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS | 2.42e-05 | 16 | 51 | 3 | MM15813 | |
| Pathway | REACTOME_UTILIZATION_OF_KETONE_BODIES | 7.66e-05 | 4 | 51 | 2 | MM15459 | |
| Pathway | KEGG_O_GLYCAN_BIOSYNTHESIS | 1.69e-04 | 30 | 51 | 3 | M6929 | |
| Pathway | REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION | 2.16e-04 | 82 | 51 | 4 | MM17230 | |
| Pubmed | 1.98e-06 | 11 | 81 | 3 | 34927784 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21307247 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24256442 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20544910 | ||
| Pubmed | Acid-sensing ion channel-1b in the stereocilia of mammalian cochlear hair cells. | 5.36e-06 | 2 | 81 | 2 | 16951561 | |
| Pubmed | Acid-Sensing Ion Channel 1a Contributes to Airway Hyperreactivity in Mice. | 5.36e-06 | 2 | 81 | 2 | 27820848 | |
| Pubmed | Conserved neuron promoting activity in Drosophila and vertebrate laminin alpha1. | 5.36e-06 | 2 | 81 | 2 | 8663504 | |
| Pubmed | Protons are a neurotransmitter that regulates synaptic plasticity in the lateral amygdala. | 5.36e-06 | 2 | 81 | 2 | 24889629 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 29544677 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12534938 | ||
| Pubmed | Laminin 2 attachment selects myofibroblasts from fetal mouse lung. | 5.36e-06 | 2 | 81 | 2 | 9728058 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9037075 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19427358 | ||
| Pubmed | Determinants of ion selectivity in ASIC1a- and ASIC2a-containing acid-sensing ion channels. | 5.36e-06 | 2 | 81 | 2 | 31952079 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22046405 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 38786099 | ||
| Pubmed | The Thumb Domain Mediates Acid-sensing Ion Channel Desensitization. | 5.36e-06 | 2 | 81 | 2 | 27015804 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 35882421 | ||
| Pubmed | Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver. | 5.36e-06 | 2 | 81 | 2 | 25114170 | |
| Pubmed | Acid-sensing ion channel 2 (ASIC2) modulates ASIC1 H+-activated currents in hippocampal neurons. | 5.36e-06 | 2 | 81 | 2 | 14960591 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20306292 | ||
| Pubmed | Presynaptic release probability is increased in hippocampal neurons from ASIC1 knockout mice. | 5.36e-06 | 2 | 81 | 2 | 18094106 | |
| Pubmed | ASIC subunit ratio and differential surface trafficking in the brain. | 5.36e-06 | 2 | 81 | 2 | 26746198 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11330065 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23135698 | ||
| Pubmed | Characterization of acid-sensing ion channels in medium spiny neurons of mouse striatum. | 5.36e-06 | 2 | 81 | 2 | 19376200 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18256271 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20657839 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9360943 | ||
| Pubmed | Acid-sensing ion channel (ASIC) 1a/2a heteromers have a flexible 2:1/1:2 stoichiometry. | 5.36e-06 | 2 | 81 | 2 | 24847067 | |
| Pubmed | Altered Expression Pattern of Acid-Sensing Ion Channel Isoforms in Piriform Cortex After Seizures. | 5.36e-06 | 2 | 81 | 2 | 25744567 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34720879 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12519755 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23644053 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19590043 | ||
| Pubmed | Identification and Function of Acid-sensing Ion Channels in RAW 264.7 Macrophage Cells. | 1.60e-05 | 3 | 81 | 2 | 30074209 | |
| Pubmed | Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function. | 1.60e-05 | 3 | 81 | 2 | 15987792 | |
| Pubmed | The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory. | 1.60e-05 | 3 | 81 | 2 | 11988176 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10567408 | ||
| Pubmed | Up-regulation of acid-sensing ion channels in the capsule of the joint in frozen shoulder. | 1.60e-05 | 3 | 81 | 2 | 26033064 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 14990679 | ||
| Pubmed | Heteromultimers of DEG/ENaC subunits form H+-gated channels in mouse sensory neurons. | 1.60e-05 | 3 | 81 | 2 | 11854527 | |
| Pubmed | Modulation of Acid-sensing Ion Channel 1a by Intracellular pH and Its Role in Ischemic Stroke. | 1.60e-05 | 3 | 81 | 2 | 27402850 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18801682 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 1373652 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 31930115 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 17548344 | ||
| Pubmed | ASIC2 subunits target acid-sensing ion channels to the synapse via an association with PSD-95. | 1.60e-05 | 3 | 81 | 2 | 19571134 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 11739374 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 22157923 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 7803849 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 35215835 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 11756565 | ||
| Pubmed | Insulin action on GABA neurons is a critical regulator of energy balance but not fertility in mice. | 1.60e-05 | 3 | 81 | 2 | 25116708 | |
| Pubmed | Subunit-dependent high-affinity zinc inhibition of acid-sensing ion channels. | 1.60e-05 | 3 | 81 | 2 | 15470133 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 28618956 | ||
| Pubmed | Role of acid-sensing ion channels in hypoxia- and hypercapnia-induced ventilatory responses. | 1.60e-05 | 3 | 81 | 2 | 29474404 | |
| Pubmed | Expression of laminin chains during myogenic differentiation. | 1.60e-05 | 3 | 81 | 2 | 7510707 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23109675 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 25988357 | ||
| Pubmed | Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. | 1.60e-05 | 3 | 81 | 2 | 7925941 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 17177258 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 16504180 | ||
| Pubmed | Acid-sensing ion channels contribute to synaptic transmission and inhibit cocaine-evoked plasticity. | 1.60e-05 | 3 | 81 | 2 | 24952644 | |
| Pubmed | Acid-sensing ion channels contribute to the effect of acidosis on the function of dendritic cells. | 1.60e-05 | 3 | 81 | 2 | 21321108 | |
| Pubmed | Citric Acid in Drug Formulations Causes Pain by Potentiating Acid-Sensing Ion Channel 1. | 1.60e-05 | 3 | 81 | 2 | 33888605 | |
| Pubmed | The subcellular distribution and function of MTA1 in cancer differentiation. | 1.60e-05 | 3 | 81 | 2 | 24970816 | |
| Pubmed | Acid sensing ion channels regulate neuronal excitability by inhibiting BK potassium channels. | 1.60e-05 | 3 | 81 | 2 | 22960074 | |
| Pubmed | Brain alpha-dystroglycan displays unique glycoepitopes and preferential binding to laminin-10/11. | 1.60e-05 | 3 | 81 | 2 | 16709410 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 11802773 | ||
| Pubmed | Expression Profiles of ASIC1/2 and TRPV1/4 in Common Skin Tumors. | 3.20e-05 | 4 | 81 | 2 | 34199609 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 25421756 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 15471860 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 15007068 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 9201115 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 32072250 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 11884454 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 2099832 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 30503172 | ||
| Pubmed | Molecular recognition by LARGE is essential for expression of functional dystroglycan. | 3.20e-05 | 4 | 81 | 2 | 15210115 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 11969289 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 5.33e-05 | 5 | 81 | 2 | 9415429 | |
| Pubmed | Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. | 5.33e-05 | 5 | 81 | 2 | 8719886 | |
| Pubmed | Cloning and chromosomal mapping of an orphan chemokine receptor: mouse RDC1. | 5.33e-05 | 5 | 81 | 2 | 9510554 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 16940157 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 11829758 | ||
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 5.33e-05 | 5 | 81 | 2 | 8613743 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 31676684 | ||
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 5.33e-05 | 5 | 81 | 2 | 9389447 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 1678389 | ||
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 7.99e-05 | 6 | 81 | 2 | 23948589 | |
| Pubmed | Essential role of alpha 6 integrins in cortical and retinal lamination. | 7.99e-05 | 6 | 81 | 2 | 9742403 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 2119632 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 9597096 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 19812697 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 22270369 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 7.99e-05 | 6 | 81 | 2 | 3794389 | |
| Pubmed | Laminin regulates PDGFRβ(+) cell stemness and muscle development. | 7.99e-05 | 6 | 81 | 2 | 27138650 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 7.99e-05 | 6 | 81 | 2 | 3109910 | |
| Cytoband | 2q21 | 2.76e-04 | 14 | 81 | 2 | 2q21 | |
| Cytoband | 14q24.3 | 6.12e-04 | 93 | 81 | 3 | 14q24.3 | |
| GeneFamily | Acid sensing ion channel subunits | 7.76e-05 | 5 | 51 | 2 | 290 | |
| GeneFamily | Acyl-CoA thioesterases | 3.46e-04 | 10 | 51 | 2 | 41 | |
| GeneFamily | Laminin subunits | 5.06e-04 | 12 | 51 | 2 | 626 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 1.43e-03 | 20 | 51 | 2 | 433 | |
| GeneFamily | Carboxypeptidases | 1.58e-03 | 21 | 51 | 2 | 1321 | |
| GeneFamily | MAGE family | 5.68e-03 | 40 | 51 | 2 | 1136 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.68e-03 | 40 | 51 | 2 | 321 | |
| GeneFamily | Kelch like|BTB domain containing | 6.25e-03 | 42 | 51 | 2 | 617 | |
| Coexpression | NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 7.00e-06 | 89 | 78 | 5 | M41173 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.60e-08 | 194 | 81 | 7 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 181 | 81 | 5 | c029cecbd7182c70b9893d8c86f334c16291a0db | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 185 | 81 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 186 | 81 | 5 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | PBMC-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 2.33e-05 | 187 | 81 | 5 | 0afef5baf3752314dbfb024790347d5e51f9b84b | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 190 | 81 | 5 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 193 | 81 | 5 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 193 | 81 | 5 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 2.92e-05 | 196 | 81 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.99e-05 | 197 | 81 | 5 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 197 | 81 | 5 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.07e-05 | 198 | 81 | 5 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | severe-Plasmablast|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.07e-05 | 198 | 81 | 5 | 0b1620ad4352ee5d599a72931aaceab4ca407498 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.07e-05 | 198 | 81 | 5 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 198 | 81 | 5 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.07e-05 | 198 | 81 | 5 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 198 | 81 | 5 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.07e-05 | 198 | 81 | 5 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | severe-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.14e-05 | 199 | 81 | 5 | 6ee4c2e6049860071169366b7e662d5c1a3cc54b | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.22e-05 | 200 | 81 | 5 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | COVID-19-kidney-Epithelial_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 6.83e-05 | 120 | 81 | 4 | e17c85d41c781a29dec7e03a8b0637dccb4346bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-05 | 131 | 81 | 4 | 72340ea139a6616a466b417949e273f473fba993 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 145 | 81 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 155 | 81 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 155 | 81 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 157 | 81 | 4 | f2bc60ec0305b056d79f1b7fd6b5e3730d606916 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 162 | 81 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.33e-04 | 165 | 81 | 4 | 34f0394356b96e31b87fb8c2fd323cf7a3f077e3 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 166 | 81 | 4 | 8e5a262dc4f04c5fc75b9a7a907832a0d7877df0 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-04 | 166 | 81 | 4 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-04 | 166 | 81 | 4 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-04 | 167 | 81 | 4 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 168 | 81 | 4 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-04 | 169 | 81 | 4 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_RSAD2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-04 | 170 | 81 | 4 | 63dfbc4746717132dc81b6bac868c7498fc96283 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 170 | 81 | 4 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 170 | 81 | 4 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 170 | 81 | 4 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 172 | 81 | 4 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 172 | 81 | 4 | c74c1d47b133eb5d0f762a06e421252a76b4672b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-04 | 175 | 81 | 4 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | facs-BAT-Fat-3m-Epithelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 177 | 81 | 4 | 3e42f6236962dd9bb23dc0d09b460ec8347d1056 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-04 | 177 | 81 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | facs-BAT-Fat-3m-Epithelial-epithelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 177 | 81 | 4 | 128186bc996784e670194c07c5352e69af5f6d68 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-04 | 177 | 81 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | facs-BAT-Fat-3m-Epithelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 177 | 81 | 4 | 7480e522cfae3f5c6c62720083750f8273725ab5 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.11e-04 | 178 | 81 | 4 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 178 | 81 | 4 | 9423e209de94d26e96117581c95dc069850225d3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 178 | 81 | 4 | 27d9826b83be67b780901429470ceb013e9039c0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.17e-04 | 179 | 81 | 4 | 381ac15d59f31bc613828bdcfbc9192b106b4d18 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 181 | 81 | 4 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 3.31e-04 | 181 | 81 | 4 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.45e-04 | 183 | 81 | 4 | dd15e1463a0d57d14800de0df0645c81c56926ae | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.45e-04 | 183 | 81 | 4 | 8ace19c38b89556d2504258a63aa5a2b14f5cd36 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 184 | 81 | 4 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 3.52e-04 | 184 | 81 | 4 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 184 | 81 | 4 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 185 | 81 | 4 | 30263c558ee331e0879abcf8b4c2427ff05f9fe7 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.60e-04 | 185 | 81 | 4 | 76304829fcfb5934188933ca20d33bc8c8b0dc91 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.60e-04 | 185 | 81 | 4 | 0595e7ab37eed690f6e3d16a9a4e9a4bce2b89db | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 185 | 81 | 4 | 1b000ca11970db8f347eb97ff44605d562aea70a | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 186 | 81 | 4 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 187 | 81 | 4 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 187 | 81 | 4 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 187 | 81 | 4 | 028e7d6e1211e123879d2f353dc32fae1185dd8e | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 187 | 81 | 4 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-04 | 190 | 81 | 4 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-04 | 190 | 81 | 4 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-04 | 190 | 81 | 4 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-04 | 190 | 81 | 4 | f39ce1678fc375eb2a3af781ddb772b0f12c5744 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-04 | 190 | 81 | 4 | 95d8dc8488e95158e84a44bb53ea4ab7bf3d44bb | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-04 | 190 | 81 | 4 | c0ee404d705b0b4f0c6ded4d070ad85eac4b16db | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-04 | 190 | 81 | 4 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 191 | 81 | 4 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 191 | 81 | 4 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-04 | 191 | 81 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-04 | 191 | 81 | 4 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-04 | 191 | 81 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.06e-04 | 191 | 81 | 4 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-04 | 191 | 81 | 4 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 192 | 81 | 4 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | COVID-19_Moderate-Plasmablast|COVID-19_Moderate / disease group, cell group and cell class | 4.14e-04 | 192 | 81 | 4 | 25c6c7a244190f82c7feab874bdec12490b7de4d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-04 | 192 | 81 | 4 | 3d777d07878269b87ec7e1f06489cae7c989d633 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 192 | 81 | 4 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.14e-04 | 192 | 81 | 4 | f345b269c8cf06b004bc9419462dbc69bffaab89 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.14e-04 | 192 | 81 | 4 | 24797e80b1f5b3ea5a0410caaf57ccf2ae9d716e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.22e-04 | 193 | 81 | 4 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | 76f0f8569255d6cdf1e3b8e954cae72e71f87157 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.22e-04 | 193 | 81 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.22e-04 | 193 | 81 | 4 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.22e-04 | 193 | 81 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.22e-04 | 193 | 81 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.22e-04 | 193 | 81 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 81 | 4 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| Drug | indole-3-carbinol | ACSL3 SLC25A35 ZAN PYROXD1 TRMO SCPEP1 ACOT1 ACOT2 ABCC2 PFKM ME2 TENM2 HDAC2 AKR7A2 KLHL4 | 7.93e-06 | 1130 | 80 | 15 | ctd:C016517 |
| Drug | AC1L3UHX | 1.22e-05 | 2 | 80 | 2 | CID000095516 | |
| Drug | AC1NQZW7 | 1.22e-05 | 2 | 80 | 2 | CID005282334 | |
| Drug | CPD-627 | 1.22e-05 | 2 | 80 | 2 | CID000439367 | |
| Drug | AC1LCVNZ | 1.22e-05 | 2 | 80 | 2 | CID000656887 | |
| Drug | naphthyl-2-methyl-succinate | 1.22e-05 | 2 | 80 | 2 | CID000656886 | |
| Drug | M 16209 | 1.84e-05 | 15 | 80 | 3 | CID000164260 | |
| Drug | p-azidobenzoyl-CoA | 3.65e-05 | 3 | 80 | 2 | CID000194163 | |
| Drug | beta-hydroxybutyrate | 4.03e-05 | 179 | 80 | 6 | CID000000441 | |
| Drug | itaconic acid | 4.56e-05 | 20 | 80 | 3 | CID000000811 | |
| Drug | 6-o-phosphonohexose | 4.84e-05 | 185 | 80 | 6 | CID000099058 | |
| Disease | N,N,N-trimethyl-5-aminovalerate measurement | 8.53e-06 | 15 | 80 | 3 | EFO_0800090 | |
| Disease | chronic musculoskeletal pain | 4.71e-04 | 12 | 80 | 2 | EFO_0022195 | |
| Disease | Congenital muscular dystrophy | 4.71e-04 | 12 | 80 | 2 | cv:C0699743 | |
| Disease | X-24588 measurement | 5.55e-04 | 13 | 80 | 2 | EFO_0800898 | |
| Disease | thalamus volume change measurement | 6.47e-04 | 14 | 80 | 2 | EFO_0021496 | |
| Disease | metabolite measurement | 8.21e-04 | 560 | 80 | 7 | EFO_0004725 | |
| Disease | Nonorganic psychosis | 8.84e-04 | 69 | 80 | 3 | C0349204 | |
| Disease | Cleft palate, cleft lip | 9.83e-04 | 279 | 80 | 5 | EFO_0003959, HP_0000175 | |
| Disease | stomach cancer (is_implicated_in) | 1.00e-03 | 72 | 80 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | response to alcohol | 1.13e-03 | 75 | 80 | 3 | EFO_0005526 | |
| Disease | acetone measurement | 1.20e-03 | 19 | 80 | 2 | EFO_0010989 | |
| Disease | Headache, HbA1c measurement | 1.47e-03 | 21 | 80 | 2 | EFO_0004541, HP_0002315 | |
| Disease | arginine measurement | 1.77e-03 | 23 | 80 | 2 | EFO_0020990 | |
| Disease | colorectal cancer, hormone replacement therapy | 1.78e-03 | 88 | 80 | 3 | EFO_0003961, MONDO_0005575 | |
| Disease | 3-hydroxybutyrate measurement | 2.09e-03 | 25 | 80 | 2 | EFO_0010982 | |
| Disease | Psychotic Disorders | 2.64e-03 | 101 | 80 | 3 | C0033975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGKVQSGMGLILQGY | 126 | Q13523 | |
| SGMGLILQGYESGSE | 131 | Q13523 | |
| VDMFGTGGGLLEYRA | 161 | Q86TX2 | |
| MYSDGQSETILGGLG | 76 | O43488 | |
| TGIVGNGLVILVMGY | 51 | P61073 | |
| MGILSDLLCGYPEGG | 316 | P78363 | |
| SGGLYGIDDTELMGA | 311 | Q9UIF9 | |
| AGEEFMGLGLGNLVS | 1031 | Q9Y6D5 | |
| MVKVGGYILGEFGNL | 496 | O95782 | |
| GLYGLAQGAMAEEEG | 1831 | Q8IYW2 | |
| YDVVVSGGGLVGAAM | 36 | Q9Y2Z9 | |
| GIVDMFGTGGGLLEY | 221 | P49753 | |
| GDLEYVGMEGGIVLS | 176 | Q96EU7 | |
| ETLYLLGMLVPGGLG | 6 | Q8IVL8 | |
| AALLGDIGGQMGLFI | 426 | Q16515 | |
| DIGGQMGLFIGASIL | 431 | Q16515 | |
| YEMEIQGQDGGGLFT | 316 | Q9Y5H2 | |
| VDLTQIPGYGLEGEM | 481 | D6REC4 | |
| LGYPSSLEEEGGLIM | 476 | Q9P2P5 | |
| PLQDYGGIMAGLGSD | 46 | Q5TGI0 | |
| ISGMDILGITGSYGL | 211 | Q6IF63 | |
| GLSYDGLLGDNQIMP | 176 | P43355 | |
| LGLTYDGMLSGEKGV | 186 | A2A368 | |
| VGYSMTEGLGQLTDG | 221 | Q16832 | |
| DKAGGYGIQALGGML | 171 | O95671 | |
| AYMELGGLGERVLGF | 556 | P54707 | |
| GLGGVECLLLAVMAY | 106 | Q7Z3T1 | |
| IGGFEAYTGGLELME | 496 | P08237 | |
| YLAGNGMPIGESENL | 751 | P09848 | |
| ADILDVVGMLYVGGL | 2876 | P24043 | |
| DMRVGVYGALGLAQG | 1021 | Q92887 | |
| LRELGQGSFGMVYEG | 1026 | P06213 | |
| LHLVMEYAGGGELFG | 146 | Q8IY84 | |
| NYGGGSSIAVLLIME | 721 | Q6XUX3 | |
| LGVATLEGPMYAVGG | 516 | Q9C0H6 | |
| QGYVIPGMDEGLLGV | 311 | O95302 | |
| YGIQVETGLMEDVGG | 376 | A8MW95 | |
| YLDTGGDVFVMLGEG | 76 | Q9Y366 | |
| AGMGQDGIVQLGASY | 461 | Q93033 | |
| IMVIGGVSEGGDYLS | 361 | Q9NVR0 | |
| IGSLDGGMLIYGGEN | 371 | Q9NY28 | |
| GGMLIYGGENVELSL | 376 | Q9NY28 | |
| GLISGLEEDQYGMPL | 386 | Q8NBF6 | |
| GLLDPGMDVYGGENI | 341 | Q6IS24 | |
| GMDVYGGENIELGIK | 346 | Q6IS24 | |
| QGEYLPDMGLGIDGV | 581 | P27658 | |
| EGLLDMLIAGGYIPA | 306 | Q96A59 | |
| ILGLGDLGVYGMGIP | 166 | P23368 | |
| GIALILMVFVNYGGG | 276 | Q68CP4 | |
| LESMGEGLFGYPLVG | 81 | A6NGE4 | |
| LLMLGGGGYTIRNVA | 296 | Q92769 | |
| MNGIRLGTYGLAEAG | 76 | Q3KQZ1 | |
| YLLENSGIGLGMQGS | 2256 | P21817 | |
| LQGMLYSLVGGQGSE | 591 | Q68CR1 | |
| VDLGLLAEMTVGYVG | 391 | Q9BVQ7 | |
| ESYGGKMAAGIGLEL | 166 | Q9HB40 | |
| QYLGGEGAIMAEIRG | 141 | Q6ZMB5 | |
| DGTMLDVEGLFYLGG | 2826 | P25391 | |
| VIILNFGGGYMGLMV | 41 | P03923 | |
| FRYLQGMLEAGEGGD | 211 | P50479 | |
| LIMGAGNLGSQLVEY | 526 | Q96PQ0 | |
| NAIMGSGILGLAYVL | 56 | Q8IZM9 | |
| LAGVVGVCLGGYLME | 381 | Q9BYT1 | |
| ELGLMTYDGNTGLLA | 1676 | Q9NT68 | |
| GVIVGGGDNGMLILY | 86 | Q9NQW1 | |
| LEFEDGMYANLGIGI | 311 | P55809 | |
| EDGMYANLGIGIPLL | 311 | Q9BYC2 | |
| GEILIGGQSVTMGYY | 526 | O95573 | |
| YEIAGLLGDIGGQMG | 426 | P78348 | |
| VAMLGAGAGVGYALL | 11 | Q6UW78 | |
| GGFGMEATLLLVVGY | 391 | Q9P2U8 | |
| EGGAIYLSGIDMIHG | 136 | Q9BU70 | |
| IIMRGEEGLDYGGIA | 546 | O00308 | |
| LSGIGQELGAGAYSM | 26 | Q12800 | |
| MIIGNGGIALELVYE | 151 | Q8WU10 | |
| GYVQGGMGALSDAIA | 281 | Q8N2H3 | |
| DLGQLASQGGLGMYE | 2181 | P12270 | |
| LDMEEGTLGYAIGGT | 171 | Q99619 | |
| EGLGVTALSTLYGGM | 36 | Q86WB7 | |
| MGGNLGEEVGYAIRF | 601 | Q92620 | |
| AMELRFVGGVYGGNI | 51 | Q8NAV1 | |
| GLYVFENGITMLDAG | 56 | Q6EMK4 | |
| GTYIGIDAMLEGLEA | 861 | P08575 | |
| GDGLQLEYEMVLTNG | 141 | Q8NBT3 | |
| GGYVLGGGAICMELL | 341 | Q7Z7E8 | |
| MYGLGEGTMLELLLG | 456 | Q9Y493 | |
| VVAAGLQYGAEGGML | 211 | Q96M32 | |
| LGYGMVGDLQKLGTS | 461 | Q8N9H8 |